Skip to main content

What the FDA labels say about taking them together

Etravirine and fosamprenavir

Etravirine's FDA label of August 15, 2023 names fosamprenavir in its drug interactions section; the fosamprenavir label PlainMeds reads does not name etravirine. The etravirine label: “Concomitant use of INTELENCE with fosamprenavir without low-dose ritonavir may cause a significant alteration in the plasma concentration of amprenavir. …”

Check it at the source: the etravirine FDA label on DailyMed (effective August 15, 2023, Janssen Products LP); the fosamprenavir FDA label on DailyMed (effective September 15, 2023, Mylan Pharmaceuticals Inc.).

What does the etravirine label say about fosamprenavir?

Etravirine label, drug interactions

Concomitant Drug Class/Drug Name: fosamprenavir (without ritonavir); Effect on Concentration of Etravirine or Concomitant Drug: ↑ amprenavir; Clinical Comment: Concomitant use of INTELENCE with fosamprenavir without low-dose ritonavir may cause a significant alteration in the plasma concentration of amprenavir. Co-administration of INTELENCE and fosamprenavir without low-dose ritonavir is not recommended.

Source: FDA drug label (Intelence), Janssen Products LP, effective August 15, 2023 (SPL set 6a9cbc29-9f15-4b24-8d86-206b82887f3d), via openFDA; the full label on DailyMed

What does the fosamprenavir label say about etravirine?

Fosamprenavir's label (effective September 15, 2023) does not name etravirine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Fosamprenavir Calcium), Mylan Pharmaceuticals Inc., effective September 15, 2023 (SPL set 3a1424d8-844c-4e24-9ebd-b2c2b61b61a3), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

5Etravirine generic labelers
2Fosamprenavir generic labelers
EtravirineFosamprenavir
Labeled forHIVHIV
Boxed warningNoNo
Pharmacy cost (NADAC)$9.94 per tablet 200 mg tabletn/a
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?